Fidelity Investments’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $28.3K | Buy |
2,516
+404
| +19% | +$4.55K | ﹤0.01% | 4145 |
|
2025
Q1 | $12K | Sell |
2,112
-288
| -12% | -$1.64K | ﹤0.01% | 4439 |
|
2024
Q4 | $23.6K | Buy |
2,400
+484
| +25% | +$4.75K | ﹤0.01% | 4146 |
|
2024
Q3 | $15.6K | Sell |
1,916
-1,785
| -48% | -$14.5K | ﹤0.01% | 4286 |
|
2024
Q2 | $49.5K | Buy |
3,701
+3,053
| +471% | +$40.8K | ﹤0.01% | 3624 |
|
2024
Q1 | $30.1K | Sell |
648
-25,882
| -98% | -$1.2M | ﹤0.01% | 3827 |
|
2023
Q4 | $1.79M | Sell |
26,530
-3,320
| -11% | -$224K | ﹤0.01% | 2331 |
|
2023
Q3 | $2.16M | Sell |
29,850
-15,333
| -34% | -$1.11M | ﹤0.01% | 2262 |
|
2023
Q2 | $3.36M | Buy |
45,183
+4,538
| +11% | +$338K | ﹤0.01% | 2173 |
|
2023
Q1 | $2.16M | Sell |
40,645
-20,570
| -34% | -$1.09M | ﹤0.01% | 2347 |
|
2022
Q4 | $4.14M | Buy |
61,215
+21,194
| +53% | +$1.43M | ﹤0.01% | 2169 |
|
2022
Q3 | $5M | Buy |
40,021
+9,892
| +33% | +$1.23M | ﹤0.01% | 2176 |
|
2022
Q2 | $2.87M | Buy |
30,129
+30,125
| +753,125% | +$2.87M | ﹤0.01% | 2393 |
|
2022
Q1 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 4775 |
|